Women’s Choice Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Women's Choice Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011873
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Women’s Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that provides branded prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, hormonal changes, compromised immune system, antibiotics, steroids and lifestyle; iron and succinic acid tablets; Urogesic Blue, a tablet used for the treatment of hypermotility, irritative voiding, urinary tract infections and discomfort from urinary diagnostic procedures; and others. The company markets its products through tele-sales and sales representatives across the US. WCP is headquartered in Berwyn, Pennsylvania, the US.

Women’s Choice Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 10
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 11
Women’s Choice Pharma Enters Into Agreement With WraSer Pharma For Trezix Oral Capsules 12
Licensing Agreements 13
Women’s Choice Pharma Enters into Licensing Agreement with Pharmics 13
Acquisition 14
Women’s Choice Pharma Acquires Edwards Pharma 14
Italfarmaco Acquires 30% Stake in Women’s Choice Pharma 15
Women’s Choice Pharmaceuticals LLC – Key Competitors 16
Women’s Choice Pharmaceuticals LLC – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Women's Choice Pharmaceuticals LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 10
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 11
Women’s Choice Pharma Enters Into Agreement With WraSer Pharma For Trezix Oral Capsules 12
Women's Choice Pharma Enters into Licensing Agreement with Pharmics 13
Women's Choice Pharma Acquires Edwards Pharma 14
Italfarmaco Acquires 30% Stake in Women’s Choice Pharma 15
Women's Choice Pharmaceuticals LLC, Key Competitors 16

★海外企業調査レポート[Women’s Choice Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition ( …
  • Meiji Holdings Co, Ltd.:企業の戦略・SWOT・財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MAGNA Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MAGNA Pharmaceuticals Inc (Magna) is a pharmaceutical company that offers non-prescription products and prescription products. The company offers dietary supplement, nasal decongestant and drowsiness antihistamine for the treatment of allergy and upper respiratory symptoms. It provides omega …
  • Hite Jinro Co., Ltd
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Daito Trust Construction Co., Ltd.
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MORRE-TEC Industries, Inc.:戦略・SWOT・企業財務分析
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Technip SA (TEC)-石油・ガス分野:企業M&A・提携分析
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • Mitchells & Butlers plc:企業の戦略・SWOT・財務情報
    Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report Summary Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SI-Bone Inc (SIBN):医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • Siegfried Holding AG (SFZN):企業の財務・戦略的SWOT分析
    Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Prinzhorn Holding GmbH:企業の戦略・SWOT・財務情報
    Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Berkshire Hathaway Energy Co:企業の戦略的SWOT分析
    Berkshire Hathaway Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Southwestern Electric Power Co:企業の戦略的SWOT分析
    Southwestern Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Bonanza Creek Energy Inc (BCEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an oil and gas company that acquires, explores, develops and produces onshore oil and liquid-rich natural gas assets. The company employs hydraulic fracturing for oil and natural gas exploration, and measurement while drilling technology or borehol …
  • Buckeye Partners, L.P.:企業の戦略・SWOT・財務情報
    Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆